Rxivist logo

Rxivist combines preprints from bioRxiv with data from Twitter to help you find the papers being discussed in your field. Currently indexing 64,782 bioRxiv papers from 287,165 authors.

Single-cell RNA sequencing reveals functional heterogeneity and sex differences of glioma-associated brain macrophages

By Natalia Ochocka, Pawel Segit, Kacper Adam Walentynowicz, Kamil Wojnicki, Salwador Cyranowski, Julian Swatler, Jakub Mieczkowski, Bozena Kaminska

Posted 30 Aug 2019
bioRxiv DOI: 10.1101/752949

Brain resident and infiltrating innate immune cells adapt a tumor-supportive phenotype in the glioma microenvironment. Flow cytometry analysis supported by a single-cell RNA sequencing study of human gliomas indicate considerable cell type heterogeneity. It remains disputable whether microglia and infiltrating macrophages have the same or distinct roles in supporting glioma progression. Here, we performed single-cell transcriptomics analyses of CD11b+ cells sorted from murine syngeneic gliomas, indicating distinct activity of microglia, infiltrating monocytes/macrophages and CNS border-associated macrophages. Our results demonstrate a previously immeasurable scale of molecular heterogeneity in the innate immune response in gliomas. We identified genes differentially expressed in activated microglia from glioma-bearing mice of different sex, and profound overexpression of the MHCII genes by male microglial cells, which we also observed in bulk human glioma samples. Sex-specific gene expression in microglia in the glioma microenvironment may be relevant to sex differences in incidence and outcomes of glioblastoma patients.

Download data

  • Downloaded 441 times
  • Download rankings, all-time:
    • Site-wide: 23,298 out of 64,798
    • In cancer biology: 714 out of 2,158
  • Year to date:
    • Site-wide: 6,867 out of 64,798
  • Since beginning of last month:
    • Site-wide: 2,034 out of 64,798

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide

Sign up for the Rxivist weekly newsletter! (Click here for more details.)